DavidWuMDPhD

Hematopathology, Molecular Genetics, Anatomic Pathology

Professor, Dept. of Laboratory Medicine and Pathology, U of WA Sch of Med

Dr. Wu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1959 NE Pacific St
Seattle, WA 98195
Phone+1 206-288-7662

Fax+1 206-606-1025

Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2003 - 2007
Harvard Medical SchoolClass of 2003

PubMed

Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632).
Frances M Cole, George S Laszlo, Margaret C Lunn-Halbert, Allie R Kehret, Patrick A Zweidler-McKay
Leukemia. 2025-03-21
1 citations
Flow Cytometry for Non-Hodgkin and Hodgkin Lymphomas.
David Gajzer, Emily Glynn, David Wu, Jonathan R Fromm
Methods in Molecular Biology. 2025-01-01
Complete loss of lineage defining antigens in two cases of B-cell malignancies following CAR-T therapy.
Alireza Torabi, Jason Love, Teresa Hyun, Angie Pham, Jordan Gauthier
Journal of Hematopathology. 2024-12-01

Abstracts/Posters

Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/Lymphoma
David Wu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Comparative Genomic Analyses Defines Shared and Unique Features of cHL and PMBL and New Mechanisms of Sensitivity to PD-1 Blockade
David Wu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

AAV Cis-Regulatory Sequences Are Correlated with Ocular Toxicity
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019